HPV-induzierte Erkrankungen

• Literatur

• 1 Hampl M. Humaner Papillomvirus. In: Oppelt P, Dörr H-G, Hrsg. Kinder- und Jugendgynäkologie. Stuttgart: Thieme; 2014
• 2 de Sanjose S, Alemany L, Ordi J et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013; 49: 3450-3461
• 3 Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003; 9: 348-359
• 4 Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76: 1888-1901
• 5 Williams AB, Darragh TM, Vranizan K et al. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83: 205-211
• 6 Winer RL, Lee SK, Hughes JP et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-226
• 7 Pagliusi SR, Aguado MT. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004; 23: 569-578
• 8 Simoens C, Goffin F, Simon P et al. Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. Br J Obstet Gynaecol 2012; 119: 1247-1255
• 9 Judson PL, Habermann EB, Baxter NN et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006; 107: 1018-1022
• 10 Sideri M, Jones RW, Wilkinson EJ et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005; 50: 807-810
• 11 Hampl M, Deckers-Figiel S, Hampl JA et al. New aspects of vulvar cancer: Changes in localization and age of onset. Gynecol Oncol 2008; 109: 340-345
• 12 Bosch FX, Broker TR, Forman D et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31 Suppl 8: 1-31
• 13 Wieland U, Pfister H et al. Papillomaviruses in human pathology: Epidemiology, pathogenesis and oncogenic role. In: Gross G, Barrasso R, eds. Human papillomavirus infection: A clinical atlas. Wiesbaden: Ullstein-Mosby; 1997: 1-18
• 14 Von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11: 598-603
• 15 Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527
• 16 AWMF. Impfprävention HPV-assoziierter Neoplasien.. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/082-002k_Impfprävention_HPV_assoziierter_Neoplasien_2013-12.pdf Stand: 20.10.2015
• 17 AWMF. Vulvakarzinom und seine Vorstufen, Leitlinie 015/059.. Im Internet: http://www.awmf.org/leitlinien/detail/ll/015-059.html Stand: 20.10.2015
• 18 Robert Koch-Institut. Impfung gegen humane Papillomaviren (HPV) für Mädchen von 12 bis 17 Jahren – Empfehlung und Begründung. Epidemiol Bull 2007; 12: 97-103